Johnson & Johnson seeks approval for phase-3 trial of its single-shot COVID vaccine in India, import license

Multinational pharma giants Johnson & Johnson have applied to India’s drug regulator to seek approval for a phase-3 clinical trial of its single-dose COVID-19 vaccine in India as well as an import license. He said that the company has demanded an early meeting of the Subject Expert Committee on COVID-19 of the Central Drugs Standard …

Johnson & Johnson seeks approval for phase-3 trial of its single-shot COVID vaccine in India, import license Read More »